Therapeutics

Barry Potter (Inventor), James Dowden (Inventor), Antony Galione (Inventor)

Research output: Patent

Abstract

The present invention relates to the use of a compound of formula (I); wherein: R1 comprises a carbonyl group and R2 is a hydrocarbyl group; optionally wherein said ring is further substituted; or a pharmaceutically acceptable salt thereof; in the manufacture of a medicament for use in one or more of: modulating the release of intracellular calcium from a store controlled by nicotinic acid adenine dinucleotide phosphate; modulating calcium spikes in mammalian cells; treating diseases in one or more of brain, heart, pancreatic cells (e.g. pancreatic acinar and pancreatic beta cells), immune cells, T-cells, haemopoietic cells including phagocytes; treating diseases in one or more of brain, heart, pancreatic cells (e.g. pancreatic acinar and pancreatic beta cells), immune cells, T-cells, haemopoietic cells including phagocytes by modulating the release of intracellular calcium from a store controlled by nicotinic acid adenine dinucleotide phosphate; treating diseases in one or more of brain, heart, and T-cells by modulating calcium spikes in mammalian cells.
Original languageEnglish
Patent numberWO2005054198 (A2)
IPCA61K31/4425
Publication statusPublished - 16 Jun 2005

    Fingerprint

Cite this

Potter, B., Dowden, J., & Galione, A. (2005). IPC No. A61K31/4425. Therapeutics. (Patent No. WO2005054198 (A2)).